M701

· Wuhan YZY Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for M701, covering 2025-07-17 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC [Phase 1, Phase 2]

See pricing